Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MEDICLIN AG Board/Management Information 2005

Apr 14, 2005

280_rns_2005-04-14_da0218a1-10ff-4c59-ac21-082612f3119f.html

Board/Management Information

Open in viewer

Opens in your device viewer

News Details

Ad-hoc | 14 April 2005 23:35

Changes to the Supervisory Board of MediClin AG

Ad hoc announcement §15 WpHG Changes to the Supervisory Board Changes to the Supervisory Board of MediClin AG Ad hoc announcement transmitted by DGAP. The issuer is solely responsible for the content of this announcement. —————————————————————————— Frankfurt am Main, 14 April, 2005 – As a consequence of the published changes in the interests held by the private shareholders of the foundation members, the Supervisory Board Members who have accompanied the company since the foundation of MediClin, have resigned from their offices after the end of this year’s general annual meeting on May 25, 2005. This relates to the Supervisory Board seats of Prof. Dr. Gerhard Schmidt (Supervisory Board Chairman), Prof. Dr. Peter Reichling and Mr. Bernd Schirmer. A successor regulation concerning the Supervisory Board seat of a shareholder of the insurance companies is upcoming. Here Mr. Frank-Rainer Vaessen (Ergo Group) will resign from office as of 25 May 2005. The Supervisory Board will propose to the general annual meeting in the agenda for this meeting it’s notification of new members. MediClin AG Postfach 16 04 19 60067 Frankfurt am Main Deutschland ISIN: DE0006595101 WKN: 659510 Listed: Amtlicher Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin- Bremen, Düsseldorf, Hamburg und Stuttgart End of ad hoc announcement (c)DGAP 14.04.2005 142335 Apr 05